Lancet
-
Biography Historical Article
Colombian physician Rodrigo Guerrero wins first Roux Prize.
-
Randomized Controlled Trial Multicenter Study
Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Rituximab could be an effective treatment for childhood-onset, complicated, frequently relapsing nephrotic syndrome (FRNS) and steroid-dependent nephrotic syndrome (SDNS). We investigated the efficacy and safety of rituximab in patients with high disease activity. ⋯ Japanese Ministry of Health, Labour and Welfare.